[Asia Economy Reporter Lee Jung-yoon] Genexine announced on the 20th that it disposed of 1,311,000 shares of Chinese company I-Mab for 35,982,170,000 KRW.



This was to secure funds for major pipeline clinical development and operational expenses, representing 6.71% of its equity capital. After the disposal, the shareholding ratio stands at 5.05% (8,488,885 shares).


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing